{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:01:45Z","timestamp":1758052905521,"version":"3.44.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015537","name":"Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.clinbiochem.2023.110685","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T19:10:43Z","timestamp":1699989043000},"page":"110685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lack of observed interference by therapeutic monoclonal antibodies in select commonly utilized immunoassays"],"prefix":"10.1016","volume":"121-122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5682-4717","authenticated-orcid":false,"given":"Kornelia D.","family":"Galior","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6176-4501","authenticated-orcid":false,"given":"Paula M.","family":"Ladwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5442-4699","authenticated-orcid":false,"given":"Melissa R.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Algeciras-Schimnich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua A.","family":"Bornhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2130-3372","authenticated-orcid":false,"given":"Darci R.","family":"Block","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola A.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Alice V.","family":"Willrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110685_b0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.trsl.2014.09.006","article-title":"Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases","volume":"165","author":"Willrich","year":"2015","journal-title":"Transl. Res."},{"issue":"12","key":"10.1016\/j.clinbiochem.2023.110685_b0010","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1373\/clinchem.2010.152116","article-title":"Interference of monoclonal antibody therapies with serum protein electrophoresis tests","volume":"56","author":"McCudden","year":"2010","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110685_b0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1373\/jalm.2019.029009","article-title":"Incidence and management of therapeutic monoclonal antibody interference in monoclonal gammopathy monitoring","volume":"5","author":"Liu","year":"2020","journal-title":"J. Appl. Lab. Med."},{"issue":"6","key":"10.1016\/j.clinbiochem.2023.110685_b0020","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1182\/blood-2018-05-848986","article-title":"A universal solution for eliminating false positives in myeloma due to therapeutic monoclonal antibody interference","volume":"132","author":"Mills","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110685_b0025","first-page":"121","article-title":"False hyperthyroidism caused by interference in immunoassays","volume":"2","author":"Jimenez Garcia","year":"2021","journal-title":"Adv. Lab. Med."},{"issue":"6","key":"10.1016\/j.clinbiochem.2023.110685_b0030","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1515\/cclm-2021-1288","article-title":"Interferences in immunoassays: review and practical algorithm","volume":"60","author":"Wauthier","year":"2022","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2023.110685_b0035","unstructured":"Aarsand AK F-CP, Webster C, Coskun A, Gonzales-Lao E, Diaz-Garzon J, Jonker N, Simon M, Braga F, Perich C, Boned B, Marques-Garcia F, Carobene A, Aslan B, Sezer E, Bartlett WA, Sandberg S. The EFLM Biological Variation Database. 2023 [Available from: https:\/\/biologicalvariation.eu\/."},{"key":"10.1016\/j.clinbiochem.2023.110685_b0040","unstructured":"Wright DR. Final Rule - Clinical Laboratory Improvement Amendments of 1988 (CLIA) Proficiency Testing - Analytes and Acceptable Performance Final Rule (CMS3355-F) Federal Register2022 [Available from: https:\/\/www.cms.gov\/files\/document\/qso-22-21-clia.pdf."},{"issue":"12","key":"10.1016\/j.clinbiochem.2023.110685_b0045","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jama.2017.13705","article-title":"Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults","volume":"318","author":"Li","year":"2017","journal-title":"JAMA"},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2023.110685_b0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jim.2010.03.012","article-title":"Rheumatoid factor interference in immunogenicity assays for human monoclonal antibody therapeutics","volume":"357","author":"Tatarewicz","year":"2010","journal-title":"J. Immunol. Methods"},{"issue":"5","key":"10.1016\/j.clinbiochem.2023.110685_b0055","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.beem.2013.05.011","article-title":"Heterophilic antibody interference in immunometric assays","volume":"27","author":"Bolstad","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110685_b0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1373\/clinchem.2004.040501","article-title":"Prevalence of heterophilic antibody interference in eight automated tumor marker immunoassays","volume":"51","author":"Preissner","year":"2005","journal-title":"Clin. Chem."},{"issue":"Pt 4","key":"10.1016\/j.clinbiochem.2023.110685_b0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1258\/acb.2009.009024","article-title":"Interference from heterophilic antibodies in TSH assays","volume":"46","author":"Halsall","year":"2009","journal-title":"Ann. Clin. Biochem."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912023002138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912023002138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:01:36Z","timestamp":1757865696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912023002138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":13,"alternative-id":["S0009912023002138"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110685","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of observed interference by therapeutic monoclonal antibodies in select commonly utilized immunoassays","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110685"}}